力诺药包：拟与关联方设合资公司 建设科创中心及配套设施项目

Core Viewpoint - The company, Linuo Pharmaceutical (301188), announced plans to establish a joint venture, Linuo Innovation Technology (Shanghe) Co., Ltd., with Linuo Group to build a technology innovation center and supporting facilities [1] Group 1: Joint Venture Details - The company will contribute land as its investment, holding a 49% stake in the joint venture, while Linuo Group will invest cash and hold a 51% stake [1] - Linuo Group is the controlling shareholder of Linuo Investment Holding Group Co., Ltd., which constitutes a related party transaction [1] Group 2: Share Acquisition - The company also announced plans to acquire 34.0465 million shares of Suzhou Chuangyang New Materials Technology Co., Ltd. through a cash agreement transfer, with a total transfer price of 84 million yuan [1]